Candel Therapeutics, Inc. Major Shareholders & Ownership History
Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
---|---|---|---|---|---|
FMR LLC | 02/13/2025 | 3.92 M | $34.06 M | 59,592.67% | 12.26% |
BAKER BROS. ADVISORS LP | 02/14/2025 | 2.98 M | $25.88 M | 100.00% | 9.31% |
02/14/2025 | 1.94 M | $16.84 M | 100.00% | 6.06% | |
BRAIDWELL LP | 02/14/2025 | 1.60 M | $13.89 M | 100.00% | 5.00% |
VANGUARD GROUP INC | 02/11/2025 | 1.34 M | $11.62 M | 41.52% | 4.18% |
BLACKROCK FUNDING, INC. /DE | 02/07/2025 | 1.18 M | $10.28 M | 5.18% | 3.70% |
PORTOLAN CAPITAL MANAGEMENT, LLC | 02/13/2025 | 753,745 | $6.54 M | 100.00% | 2.35% |
HALTER FERGUSON FINANCIAL INC. | 02/11/2025 | 681,334 | $5.91 M | 123.73% | 2.13% |
SUSQUEHANNA INTERNATIONAL GROUP, LLP | 02/14/2025 | 661,500 | $5.74 M | 2,702.97% | 2.07% |
STATE STREET CORP | 02/14/2025 | 560,969 | $4.87 M | 14.02% | 1.75% |
GEODE CAPITAL MANAGEMENT, LLC | 02/12/2025 | 455,424 | $3.95 M | 1.43% | 1.42% |
SANDS CAPITAL VENTURES, LLC | 02/13/2025 | 405,837 | $3.52 M | 0.00% | 1.27% |
SUSQUEHANNA INTERNATIONAL GROUP, LLP | 02/14/2025 | 370,200 | $3.21 M | 474.84% | 1.16% |
SUSQUEHANNA INTERNATIONAL GROUP, LLP | 02/14/2025 | 294,443 | $2.56 M | 117.37% | 0.92% |
UBS GROUP AG | 02/14/2025 | 156,806 | $1.36 M | 1,560.03% | 0.49% |
HB WEALTH MANAGEMENT, LLC | 01/15/2025 | 87,300 | $696,189 | 54.08% | 0.27% |
BRIDGEWAY CAPITAL MANAGEMENT, LLC | 02/14/2025 | 77,195 | $670,053 | -4.22% | 0.24% |
NUVEEN ASSET MANAGEMENT, LLC | 02/14/2025 | 68,226 | $592,202 | 3.03% | 0.21% |
GOLDMAN SACHS GROUP INC | 02/11/2025 | 65,236 | $566,249 | 115.58% | 0.20% |
BIRCHVIEW CAPITAL, LP | 02/14/2025 | 60,000 | $520,800 | 100.00% | 0.19% |
CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 02/06/2025 | 52,190 | $453,009 | 11.57% | 0.16% |
MAVEN SECURITIES LTD | 02/14/2025 | 51,731 | $449,025 | 100.00% | 0.16% |
MML INVESTORS SERVICES, LLC | 02/13/2025 | 49,235 | $427,000 | 120.66% | 0.15% |
BANK OF NEW YORK MELLON CORP | 02/04/2025 | 44,980 | $390,425 | 0.00% | 0.14% |
COMMONWEALTH EQUITY SERVICES, LLC | 02/10/2025 | 41,098 | $357,000 | 100.00% | 0.13% |
OPPENHEIMER & CO INC | 02/05/2025 | 37,915 | $329,102 | 100.00% | 0.12% |
BARCLAYS PLC | 02/13/2025 | 34,317 | $297,000 | 19.62% | 0.11% |
02/14/2025 | 32,900 | $285,572 | 100.00% | 0.10% | |
MILLENNIUM MANAGEMENT LLC | 02/14/2025 | 31,626 | $274,514 | 130.64% | 0.10% |
DEUTSCHE BANK AG\ | 02/14/2025 | 31,522 | $273,611 | 5,814.07% | 0.10% |
JANE STREET GROUP, LLC | 02/14/2025 | 30,200 | $262,136 | 100.00% | 0.09% |
HEIGHTS CAPITAL MANAGEMENT, INC | 02/14/2025 | 30,000 | $260,400 | 100.00% | 0.09% |
RHUMBLINE ADVISERS | 01/30/2025 | 26,272 | $228,032 | 17.00% | 0.08% |
AQR CAPITAL MANAGEMENT LLC | 02/14/2025 | 21,859 | $189,736 | 9.10% | 0.07% |
02/14/2025 | 20,000 | $173,600 | 100.00% | 0.06% | |
SQUAREPOINT OPS LLC | 02/14/2025 | 19,311 | $167,619 | 86.60% | 0.06% |
VONTOBEL HOLDING LTD. | 01/30/2025 | 19,000 | $164,920 | -13.64% | 0.06% |
CITIGROUP INC | 02/12/2025 | 18,603 | $161,474 | 28.39% | 0.06% |
JANE STREET GROUP, LLC | 02/14/2025 | 16,572 | $143,845 | -49.47% | 0.05% |
METLIFE INVESTMENT MANAGEMENT, LLC | 02/13/2025 | 13,773 | $119,550 | 9.68% | 0.04% |
MIRAE ASSET GLOBAL ETFS HOLDINGS LTD. | 02/14/2025 | 12,165 | $105,592 | 12.38% | 0.04% |
OXFORD ASSET MANAGEMENT LLP | 02/14/2025 | 12,003 | $104,186 | 100.00% | 0.04% |
TRANSFORM WEALTH, LLC | 01/17/2025 | 11,577 | $100,489 | 100.00% | 0.04% |
COREBRIDGE FINANCIAL, INC. | 02/11/2025 | 10,770 | $93,484 | 0.27% | 0.03% |
ALLIANCEBERNSTEIN L.P. | 02/12/2025 | 10,660 | $92,529 | 0.00% | 0.03% |
JPMORGAN CHASE & CO | 02/12/2025 | 10,426 | $90,498 | 15.19% | 0.03% |
WELLS FARGO & COMPANY/MN | 02/13/2025 | 10,122 | $87,859 | 63.60% | 0.03% |
02/14/2025 | 6,046 | $42,745 | 100.00% | 0.02% | |
02/11/2025 | 5,419 | $47,037 | 100.00% | 0.02% | |
SIMPLEX TRADING, LLC | 02/11/2025 | 4,569 | $39,000 | -79.99% | 0.01% |
Candel Therapeutics, Inc. institutional Ownership - FAQ's
During the previous two years, 65 institutional investors and hedge funds held shares of Candel Therapeutics, Inc.. The most heavily invested institutionals were:
FMR LLC: 3.92 M
BAKER BROS. ADVISORS LP: 2.98 M
BRAIDWELL LP: 1.6 M
VANGUARD GROUP INC: 1.34 M
BlackRock Funding, Inc. /DE: 1.18 M
Portolan Capital Management, LLC: 753,745
56.00% of Candel Therapeutics, Inc. stock is owned by institutional investors.
Institutional investors have bought a total of 18.42 M shares in the last 24 months. This purchase volume represents approximately $160.23 M in transactions.